ÂÜÀòÂÒÂ×

Jodie Morrison serves as the CEO and Board Member at Q32 Bio Inc. since September 2022 and also holds the position of Board Member at Verve Therapeutics beginning June 2024. As the Founder of The CEO Forum established in March 2020, Jodie aids biotech CEOs in navigating challenges such as the COVID-19 crisis and the SVB banking crisis. Additional roles include being a Board Member at Rectify Pharma and Keryx Biopharmaceuticals, a Venture Partner/Advisor at Atlas Venture, and Principal and Founder of Morrison Advisory since May 2017. Jodie has previously held executive positions, notably as CEO of Cadent Therapeutics until its sale to Novartis. Jodie possesses a Business Certification from MIT Sloan School of Management, a Clinical Research Certification from Boston University School of Medicine, and a BS in Neuroscience from Mount Holyoke College.